Intermed Instruments Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 0.91 M
- Company Age 14 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 19.79%
- Profit Growth 330.84%
- Ebitda -88.84%
- Net Worth 17.87%
- Total Assets 14.37%
About Intermed Instruments
Intermed Instruments Private Limited (IIPL) is a Private Limited Indian Non-Government Company incorporated in India on 31 March 2010 and has a history of 14 years and ten months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.91 M, as per Ministry of Corporate Affairs (MCA) records.
Sanjay Gupta and Shraey Gupta serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U33110MH2010PTC415673
- Company No.
201004
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Mar 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Intermed Instruments?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Gupta  | Director | 31-Mar-2010 | Current |
| Shraey Gupta | Director | 31-Mar-2010 | Current |
Financial Performance of Intermed Instruments.
Intermed Instruments Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 19.79% increase. The company also saw a substantial improvement in profitability, with a 330.84% increase in profit. The company's net worth Soared by an impressive increase of 17.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Intermed Instruments?
In 2023, Intermed Instruments had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Plastx Labs Private LimitedSanjay Gupta is a mutual person
Acer Biomedicals LlpShraey Gupta is a mutual person
Bioline Diagnostics LlpSanjay Gupta and Shraey Gupta are mutual person
- Sanjay Gupta Estates Llp
Sanjay Gupta is a mutual person
- Gujrat Essence Mart Private Limited
Sanjay Gupta and Shraey Gupta are mutual person
- Avishkar International Private Limited
Sanjay Gupta is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Intermed Instruments?
Unlock and access historical data on people associated with Intermed Instruments, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Intermed Instruments, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Intermed Instruments's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
